Romlusevimab
Product Specifications
CAS Number
2509447-08-7
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Purity
1
Bioactivity
Romlusevimab (BRII-198) is a recombinant antibody targeting the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), with antiviral activity, used for research on COVID-19 infection.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1037941-01 100 mg
(1R,2R) -2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) cyclohexane-1-carboxylic acid
Ask
View Details OR1037941-02 250 mg
(1R,2R) -2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) cyclohexane-1-carboxylic acid
Ask
View Details 
OR1037941-03 1 g
(1R,2R) -2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) cyclohexane-1-carboxylic acid
Ask
View Details OR1037941-04 5 g
(1R,2R) -2- ((((9H-fluoren-9-yl) methoxy) carbonyl) amino) cyclohexane-1-carboxylic acid
Ask
View Details